Clough Capital Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,036
Closed -$303K 111
2024
Q4
$303K Sell
21,036
-2,964
-12% -$45.9K 0.03% 115
2024
Q3
$380K Sell
24,000
-24,000
-50% -$378K 0.04% 124
2024
Q2
$737K Hold
48,000
0.08% 99
2024
Q1
$787K Sell
48,000
-45,000
-48% -$710K 0.09% 86
2023
Q4
$1.36M Sell
93,000
-56,782
-38% -$793K 0.15% 92
2023
Q3
$2.16M Sell
149,782
-139,954
-48% -$2.18M 0.23% 92
2023
Q2
$4.76M Buy
289,736
+46,600
+19% +$759K 0.48% 67
2023
Q1
$4.06M Buy
243,136
+40,400
+20% +$651K 0.44% 81
2022
Q4
$3.13M Buy
+202,736
New +$3.14M 0.32% 80
2021
Q2
Sell
-103,900
Closed -$2.73M 139
2021
Q1
$2.73M Buy
+103,900
New +$2.95M 0.12% 92

Other funds holding BMEZ

Clough Capital Partners's BMEZ Position: Q1 2025 in Review

Clough Capital Partners sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2025, closing a stake of 21,036 shares — an estimated $303K sold.

Clough Capital Partners first reported a position in BMEZ in Q1 2021 and held it in 10 quarters. The position peaked at $4.76M in Q2 2023. 98 funds tracked by Wall St. Rank hold BMEZ as of Q1 2025.

  • Clough Capital Partners reported no remaining BlackRock Health Sciences Trust II position as of Q1 2025 after selling out during the quarter.
  • Clough Capital Partners sold 21,036 BlackRock Health Sciences Trust II shares in Q1 2025, an estimated $303K.
  • Clough Capital Partners first reported a position in BlackRock Health Sciences Trust II in Q1 2021 and held it in 10 quarters.
  • Clough Capital Partners's BlackRock Health Sciences Trust II position peaked at $4.76M in Q2 2023.
  • 98 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2025.

Based on Clough Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.